{
    "type": "ETP",
    "ucits": false,
    "replication_method": "synthetic",
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": true,
    "complex_factors": [
        "Leverage",
        "Inverse exposure",
        "Synthetic replication via funded swap",
        "Counterparty risk",
        "Daily reset and compounding effects"
    ],
    "classification": "complex",
    "supporting_data": "The GraniteShares 3x Short Barclays Daily ETP is a collateralised Exchange Traded Product (ETP) that seeks to provide -3 times the daily performance of Barclays PLC shares through tracking the Solactive Daily Leveraged 3x Short Barclays PLC Index. The product uses a funded swap agreement with Natixis as the swap counterparty, with collateral held at BNY Mellon, indicating synthetic replication. The product explicitly uses leverage (3x inverse exposure) and daily reset of leverage, which introduces compounding effects that cause returns over periods longer than one day to deviate significantly from the underlying asset's performance multiplied by leverage. The risk indicator is at the highest level (7/7), reflecting very high risk and complexity. The product carries significant counterparty risk, as the ability to pay depends on the swap provider's performance and collateral realisation. The product is not UCITS compliant. The KIID and factsheet warn that the product is intended only for sophisticated investors with specific knowledge of leveraged and inverse products, and that it may be difficult to understand. The use of swaps, leverage, inverse exposure, and daily compounding effects are all complexity drivers under MiFID II. There is no capital protection, and the product can lose the full invested amount. The costs include swap fees embedded in ongoing costs. These factors combined classify the product as complex under MiFID II rules."
}